...
首页> 外文期刊>EBioMedicine >Zika Virus Infection in Dexamethasone-immunosuppressed Mice Demonstrating Disseminated Infection with Multi-organ Involvement Including Orchitis Effectively Treated by Recombinant Type I Interferons
【24h】

Zika Virus Infection in Dexamethasone-immunosuppressed Mice Demonstrating Disseminated Infection with Multi-organ Involvement Including Orchitis Effectively Treated by Recombinant Type I Interferons

机译:地塞米松免疫抑制小鼠中的寨卡病毒感染,表现出通过重组I型干扰素有效治疗的包括睾丸炎在内的多器官参与的传播感染。

获取原文
           

摘要

Abstract Background Disseminated or fatal Zika virus (ZIKV) infections were reported in immunosuppressed patients. Existing interferon-signaling/receptor-deficient mouse models may not be suitable for evaluating treatment effects of recombinant interferons. Methods We developed a novel mouse model for {ZIKV} infection by immunosuppressing BALB/c mice with dexamethasone. Results Dexamethasone-immunosuppressed male mice (6–8 weeks) developed disseminated infection as evidenced by the detection of ZIKV-NS1 protein expression and high viral loads in multiple organs. They had ≥ 10% weight loss and high clinical scores soon after dexamethasone withdrawal (10 dpi), which warranted euthanasia at 12 dpi. Viral loads in blood and most tissues at 5 dpi were significantly higher than those at 12 dpi (P < 0.05). Histological examination revealed prominent inflammatory infiltrates in multiple organs, and {CD45} + and {CD8} + inflammatory cells were seen in the testis. These findings suggested that clinical deterioration occurred during viral clearance by host immune response. Type I interferon treatments improved clinical outcome of mice (100% vs 0% survival). Conclusions Besides virus dissemination, inflammation of various tissues, especially orchitis, may be potential complications of {ZIKV} infection with significant implications on disease transmission and male fertility. Interferon treatment should be considered in patients at high risks for ZIKV-associated complications when the potential benefits outweigh the side effects of treatment.
机译:摘要背景在免疫抑制的患者中报告了传播性或致命性寨卡病毒(ZIKV)感染。现有的干扰素信号/受体缺陷型小鼠模型可能不适合评估重组干扰素的治疗效果。方法我们通过用地塞米松免疫抑制BALB / c小鼠,建立了{ZIKV}感染的新型小鼠模型。结果地塞米松免疫抑制的雄性小鼠(6-8周)发生了弥漫性感染,这可通过检测ZIKV-NS1蛋白表达和在多个器官中高病毒载量来证明。地塞米松戒断(10 dpi)后不久,他们的体重减轻≥10%,临床评分较高,这可确保在12 dpi时实现安乐死。 5 dpi时血液和大多数组织中的病毒载量显着高于12 dpi时(P <0.05)。组织学检查显示多个器官中明显的炎性浸润,并且在睾丸中发现了{CD45} +和{CD8} +炎性细胞。这些发现表明,在通过宿主免疫应答进行病毒清除过程中发生了临床恶化。 I型干扰素治疗可改善小鼠的临床结局(100%vs. 0%存活率)。结论除了传播病毒外,各种组织的炎症,特别是睾丸炎,可能是{ZIKV}感染的潜在并发症,对疾病传播和男性生育能力有重要影响。当潜在的利益大于治疗的副作用时,应考虑在ZIKV相关并发症高风险患者中考虑干扰素治疗。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号